SYNGENE
Biocon Sells 9.96% Stake In Contract Research Firm Syngene Via Open Market
Banking - Published date: .
Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing Read more
Will Invest Rs 2,000 Cr In Small Molecules Segment In 3-4 Years: Biocon MD
Banking - Published date: .
In a Q&A, Biocon CEO and MD Siddharth Mittal explains why he believes his company is on track to achieve the $1 bill... Read more